AivoCode
San Diego
About AivoCode
AivoCode Inc. is an emerging biotechnology company focused on critical neurological diseases such as brain injury, Alzheimer’s disease and other degenerative disorders. AivoCode’s technology is based on proprietary and unique peptides that specifically recognize molecular changes in brain injuries and neurodegenerative diseases. These peptides enhance the delivery of a variety of therapeutics and diagnostic agents into affected regions of the brain and can also possesses intrinsic therapeutic properties. AivoCode’s technology development was funded entirely by non-dilutive federal grant funding.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Funding stage: Seed
- Last round: Grant (Mar 2024)
- Website: aivocode.com
- Phone: 832-287-7308
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aivocode-12710 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.